Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Volume of shares traded on the OTC Moscow Exchange exceeded ₽113 billion

7/22/24 MOEX

Yakovlev reported for 6 months of 2024 by RAS

7/22/24 IRKT

APRI has started collecting applications for participation in the IPO

7/22/24 APRI

Severstal reported for 6 months of 2024 by IFRS

7/22/24 CHMF

Board of Directors of Severstal recommended that dividends be paid for 6 months 2024

7/22/24 CHMF

Severstal's sales in the 1st half of the year decreased by 6%

7/22/24 CHMF

Rusagro's revenues in the 1st half of the year increased by 30%

7/22/24 AGRO

Moscow Exchange launched its first Pre-IPO

7/19/24 MOEX

SR Space has started collecting applications for Pre-IPO participation

7/19/24 OTCI

Lenenergo purchases charging stations

7/19/24 LSNG